CEDAR KNOLLS, N.J.,
Feb. 15, 2018 /PRNewswire/
-- MYOS RENS Technology Inc. ("MYOS" or "the Company")
(NASDAQ: MYOS), a bionutrition company and owner of
Fortetropin®, the fertilized egg yolk-based product that
helps build lean muscle in conjunction with resistance training,
announced today that it will showcase Fortetropin® at
the Arnold Fitness EXPO to be held during the Arnold Sports
Festival March 2-4, 2018, at the
Greater Columbus Convention Center
in Columbus, Ohio.
Arnold Fitness EXPO attendees are encouraged to visit booth #513
to sample the Qurr® line of products, available in
delicious powders, puddings and shakes. Each product contains MYOS'
proprietary ingredient Fortetropin®, which is clinically
shown to increase lean muscle size and mass.
Fortetropin® is a unique bioactive composition derived
from fertilized egg yolk and processed using patented technology,
thereby retaining its nutrient-dense nature and biological
integrity. Attendees will also be able to purchase Qurr
products at special EXPO discounted prices.
Joseph Mannello, Chief Executive
Officer of MYOS, commented, "The "Arnold" is the most iconic
event in the fitness world; over 200,000 people flock to the show
annually, which features 20,000 athletes from 80 nations, non-stop
competitions and entertainment over four days, and over 1,000
booths of fitness equipment, apparel and nutrition. We
believe Fortetropin® is a perfect fit for this crowd and
the Arnold Sports Festival, an excellent platform to fast-track
brand awareness."
About MYOS RENS Technology Inc.
MYOS RENS Technology Inc. (MYOS), "The Muscle Company™", is a
Cedar Knolls, NJ-based
bionutrition company that develops and markets products that
improve muscle health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg yolk-based product
manufactured via a proprietary process to retain and optimize its
biological activity. Fortetropin® has been clinically
shown to increase muscle size and lean body mass in conjunction
with resistance training. MYOS believes Fortetropin® has
the potential to redefine existing standards of physical health and
wellness. For more information, please visit www.MYOSRENS.com.
Forward-Looking Statements
Any statements
in this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the successful launch of our products,
including Qurr® products, the success of our
research and development, the results of the clinical evaluation of
Fortetropin® and its effects, the ability to enter into new
partnership opportunities and the success of our existing
partnerships, the ability to generate the forecasted revenue stream
and cash flow from sales of our products, the ability to continue
increasing our revenue and gross profit margins, the ability to
achieve a sustainable, profitable business, the effect of economic
conditions, the ability to protect our intellectual property
rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after
the date on which such statement is made except as required by
law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
Investor Relations:
Porter LeVay & Rose
Michael Porter, President
Phone: 212-564-4700
Email: MYOS@plrinvest.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-to-showcase-fortetropin-and-the-qurr-line-of-muscle-health-products-at-the-2018-arnold-sports-festival-in-columbus-oh-from-march-2-4-2018-300599193.html
SOURCE MYOS RENS Technology